6.17-6.23 | 临床研究顶刊快报
文摘
教育
2024-06-24 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Melani C, Lakhotia R, Pittaluga S, Phelan JD, Huang DW, Wright G, et al. Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma. New England Journal of Medicine. 2024;390(23):2143-55.2. Quiroz YT, Aguillon D, Aguirre-Acevedo DC, Vasquez D, Zuluaga Y, Baena AY, et al. APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease. New England Journal of Medicine. 2024;390(23):2156-64.3. Gibbs KW, Semler MW, Driver BE, Seitz KP, Stempek SB, Taylor C, et al. Noninvasive Ventilation for Preoxygenation during Emergency Intubation. New England Journal of Medicine. 2024;390(23):2165-77.4. Chen Y, Xu Y, Li H, Sun T, Cao X, Wang Y, et al. A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia. New England Journal of Medicine. 2024;390(23):2178-90.5. Laslett LL, Scheepers LEJM, Antony B, Wluka AE, Cai G, Hill CL, et al. Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2024;331(23):1997-2006.6. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, et al. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. 2024;331(23):2007-17.7. Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, et al. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. 2024;331(23):2018-28.8. Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, et al. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. The Lancet. 2024;403(10445):2695-708.9. Gelderblom H, Bhadri V, Stacchiotti S, Bauer S, Wagner AJ, van de Sande M, et al. Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2024;403(10445):2709-19.10. Liu X, Zhang Y, Yang K-Y, Zhang N, Jin F, Zou G-R, et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. The Lancet. 2024;403(10445):2720-31.11. Liu G-Y, Ye Y-F, Jiang Y-F, Chen GJ, Xia W-X, Huang Y-S, et al. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ. 2024;385:e077890. 12. Bergendahl S, Jonsson M, Hesselman S, Ankarcrona V, Leijonhufvud Å, Wihlbäck A-C, et al. Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA): multicentre, open label, randomised controlled trial. BMJ. 2024;385:e079014.部分文字参考新英格兰医学前沿。
